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Two human tumor cell lines were analyzed for the production of human antileucoprotease (ALP). One of 
them, a human squamous lung carcinoma cell line (HS-24) synthesized, as confirmed by Western blot anal- 
ysis, high amounts of ALP in serum-free medium. The supernatant inhibited elastase, chymotrypsin and 
trypsin. Northern blot analysis with an 18-mer adiolabelled oligonucleotide, derived from an ALP specific 
cDNA clone, revealed a specific mRNA of about 700-800 nucleotides in HS-24 tumor cells. In contrast° 
a secondary human lung tumor cell line (SB-3), derived from the adrenal cortex, did not synthesize ALP 
when assayed under identical conditions. The supernatant inhibited only trypsin and chymotrypsin. 
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1. INTRODUCTION 
Serine protease inhibitors are secreted not only 
from normal tissue but also from cancerous tissue 
and different tumor cell lines [1-3]. It has been 
previously shown that the HPSTI,  primarily a pan- 
creatic secretory product, is also secreted from dif- 
ferent human tumor cell lines in serum-free 
medium. Interestingly, this inhibitor seems to act 
as a growth stimulating factor for human en- 
dothelial ceils [1]. A further human serine protease 
inhibitor, antileucoprotease (ALP), has been 
isolated from various human mucous tissues and 
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their secretions [4-9]. The inhibitor is acid-stable 
and has a strong affinity for neutrophil elastase, 
cathepsin G, trypsin and chymotrypsin, enzymes 
playing key roles in causing lung emphysema 
[10,11]. It has been shown that ALP is secreted 
from nonciliated (non-goblet) cells in the lung 
tissue [12] and recently its primary structure has 
been elucidated by the cloning of its cDNA [13]. 
The molecular mass has been determined as 11 726 
Da. 
In this report we show for the first time that a 
primary human lung tumor cell line (HS-24) 
secretes ALP in the serum-free medium, whereas a
secondary lung metastasis cell line (SB-3), pro- 
duces a serine protease inhibitor different from 
ALP. 
Abbreviations: TCM, tumor-conditioned medium; 
ALP, antileucoprotease; PBS, phosphate-buffered 
saline; HPSTI, human pancreatic secretory trypsin in- 
hibitor; SSC, sodium chloride, sodium citrate; synthetic 
substrates are --bbreviated according to the IUPAC-IUB 
rules r.~ ~ -:viation of amino acids; substituents: 
' J ,  ,,~=:.hoxy; Suc, 3-carboxypropionyl; Bz, benzoyl; 
pNa, p-nitroanilide 
2. EXPERIMENTAL 
2.1. Serum-free supernatants of lung tumor cell 
lines 
For production of serum-free tumor- 
conditioned medium (TCM), two human lung 
tumor cell lines (a primary cell line, designated 
HS-24 [14,15], and a secondary cell line, 
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designated SB-3) were cultured in serum-free 
medium and their supernatants were harvested us- 
ing a method similar to that of Fett et al. [16]. The 
cell lines were routinely grown in serum- 
conditioned RPMI-1640 medium. After reaching 
confluence, 2 x 10 7 tumor cells/175 cmz tissue 
flask, the cells were washed extensively with PBS 
and cultured in serum-free medium for 2-3 days. 
Collection and storage of the serum-free TCM 
were performed as described in [16]. For produc- 
tion of cell lysates 2 x 10 7 tumor cells were lysed 
in double distilled water and the supernatants were 
collected after centrifugation. 
2.2. Western blot analysis 
Western blotting was carried out as described in 
[17-19]. Rabbit anti-ALP antiserum was a gift 
from Professor H. Fritz (Inst. Klin. Chemie und 
Klin. Biochemie der Chirurgischen Klinik In- 
nenstadt der Universit~it Mfinchen). The second 
antibody, a goat anti-rabbit IgG-peroxidase con- 
jugate, was purchased from Sigma. 
2.3. Enzyme inhibition assays 
Human elastase was a gift from Dr R. Geiger 
(Inst. Klin. Chemie und Klin. Biochemie der 
Chirurgischen Klinik Innenstadt der Universit~t 
Mfinchen). Bovine trypsin and bovine chymotryp- 
sin were purchased from Merck. The trypsin in- 
hibition assay was performed as described in 
[20-22]. Inhibition of bovine chymotrypsin and 
human elastase was carried out according to 
DelMar et al. [23] and Geiger et al. [24]. Inhibition 
of elastase was measured with the substrate 
MeOSuc-Ala-Ala-Pro-Val-pNA. Measurements 
and inhibition of chymotrypsin were performed 
with Suc-Ala-Ala-Pro-Phe-pNA substrate and Bz- 
L-Arg-pNA, respectively. 
2.4. RNA isolation and Northern blotting 
Total cellular RNA from human HS-24 tumor 
cells was prepared according to the procedure of 
Chirgwin [25]. 10/~g poly(A) ÷ RNA was denatured 
[26], electrophoresed and transferred onto a 
nitrocellulose filter as described [27]. As hybridiza- 
tion probe an 18-mer oligonucleotide was syn- 
thesized on an automated DNA synthesizer 
(Applied Biosystems). The nucleotide sequence 
was derived from the cloned ALP cDNA [13] and 
codes for amino acids 50-55 of the mature ALP. 
Hybridization was performed with a 10 6 cpm/ml 
hybridization solution at 51°C for 12 h. After 
hybridization the filter was washed at 42°C in 0.2 
x SSC(1 x SSC = 150mMNaC1, 15mMsodium 
citrate) for 20 min and exposed for 2 days. 
3. RESULTS 
ALP has been shown to be secreted by mucous 
secreting cells in the lung, especially the non-goblet 
cells [12]. In order to determine, whether human 
lung tumor cell lines also secrete ALP two dif- 
ferent human tumor cell lines were tested, firstly, 
a primary squamous carcinoma cell line (HS-24) 
and secondly, a secondary lung tumor cell line 
(SB-3), which is derived from the adrenal cortex. 
These human cell lines were grown in serum-free 
medium and their supernatants were harvested as 
described [16]. Proteins present in the supernatant 
were then analyzed in a Western blot assay (fig. 1), 
using antiserum against isolated ALP from human 
seminal plasma. Proteins of both supernatants 
were separated on 15°70 SDS gels and were then 
blotted onto nitrocelluloses by electrophoretic 
transfer. Fig.1 shows that two proteins in the 
HS-24 supernatant are detected by anti-ALP an- 
tibodies. In contrast o the HS-24 TCM, no cross- 
reactivity was found with proteins secreted from 
the SB-3 cell line. Furthermore, the immunoreac- 
tire proteins present in the HS-24 supernatant 
comigrated with two ALP forms isolated from 
human seminal plasma. The smaller molecular 
mass form probably results from a limited pro- 
teolysis at the early stage of serum collection. For 
comparison, proteins of lysed cells were also 
analysed in the Western blot assay. As shown in 
fig. 1 four proteins cross-reacted with anti-ALP an- 
tiserum; one protein comigrated with the 11 700 Da 
form. 
Interestingly, two proteins with molecular 
masses above 11 700 Da and one with a molecular 
mass smaller than native ALP were also im- 
munoreactive with the antibodies. However, these 
proteins have not yet been characterized. 
Because ALP has inhibitory activities against 
trypsin, chymotrypsin and elastase, supernatants 
of HS-24 and SB-3 tumor ceils were tested for the 
inhibition of these three proteases. 80 pmol bovine 
trypsin were preincubated with increasing amounts 
of tumor cell supernatants and the release of 
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Fig.1. SDS-polyacrylamide g l electrophoresis of SB-3 
supernatant (1), of SB-3 cell lysate (4), of HS-24 super- 
natant (3) and of HS-24 cell lysate (5). For comparison 
1/zg ALP from seminal plasma was also electrophoresed 
on a 15070 gel (2). (A) The proteins were stained ac- 
cording to the method of Oakley et al. [28] after elec- 
trophoresis. (B) Western blot analysis [17-19] of the 
electrophoresed proteins was performed with rabbit 
anti-ALP antiserum and goat anti-rabbit IgG-peroxidase 
conjugate as described in section 2. 
4-nitroaniline from Bz-L-Arg-pNa was measured 
at 405 nm. Similarly, the inhibition of 11 pmol 
human elastase and 3 pmol bovine chymotrypsin 
was measured with their specific substrates as 
described in section 2. The protein concentration 
of both supernatants was determined according to 
Bradford [29]. For inhibition measurements both 
supernatants were concentrated 15-fold. 
Fig.2 shows that 5-15/~g total protein of HS-24 
TCM exhibited 50°7o inhibition of elastase, trypsin 
and chymotrypsin. Control experiments with 
ALP,  isolated from seminal plasma, have shown 
that 200-300 ng purified ALP exhibits about 50°70 
inhibition of chymotrypsin, trypsin and elastase. 
From these data and on the basis of our Western 
blot results we conclude, that 1 °7o of the total pro- 
tein in the HS-24 supernatant is antileucoprotease. 
In contrast to the inhibitory activities seen with 
HS-24 TCM, no inhibition of human elastase was 
detected with SB-3 supernatant; however, SB-3 
TCM inhibited chymotrypsin and trypsin to a 
similar extent as obtained with HS-24 TCM (fig.2). 
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Fig.2. Enzyme inhibition assays of human elastase (A), 
bovine chymotrypsin (B) and bovine trypsin (C) with 
HS-24 supernatant (= --), HS-24 cell lysate (m----o) 
and SB-3 supernatant (o-----o) were performed as 
described in section 2. 
Furthermore, comparing the inhibitory activities 
between similar amounts of secreted protein and 
cytoplasmic protein from lysed HS-24 cells, a 
significant reduction of inhibitory activity was 
observed with the latter (fig.2). 
In order to prove whether the ALP mRNA of 
cervix uterus is identical to that of human 
squamous lung carcinoma cell line (HS-24), we 
performed Northern blot analysis using a specific 
radiolabelled 18-mer oligonucleotide. 10/~g human 
lung tumor cell poly(A) ÷ RNA were tested. After 
hybridization and exposure of the hybridized filter 
for 2 days, a 700-800 nucleotide long mRNA 
species could be detected. As shown in fig.3 the 
length of tumor-derived mRNA agreed with the 
reported length of ALP mRNA in cervix uterus 
[13]. 
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Fig.3. Northern blot analysis of human RNA from 
HS-24 tumor cells. RNA samples were denatured with 
glyoxal, separated on a 1.2°70 agarose gel and transferred 
to nitrocellulose. The RNA was hybridized to 5' -labelled 
synthetic 18-mer oligonucleotide. 10/zg poly(A) + RNA 
from HS-24 tumor cells (lane 2) were loaded. As a con- 
trol 25 /zg total celluar RNA from human spleen was 
transferred (lane 1). 
4. DISCUSSION 
Human squamous lung carcinoma cells (HS-24) 
in culture synthesize antileucoprotease that is 
structurally related or identical to ALP isolated 
from human seminal plasma. The evidence for this 
structural relationship is demonstrated by the 
facts, that (i) anti-ALP antiserum cross-reacts with 
ALP from HS-24 TCM, (ii) immunoreactive pro- 
teins comigrate with the ALP forms, isolated from 
seminal plasma, (iii) HS-24 TCM exhibits inhibi- 
tion of the same proteases as ALP from seminal 
plasma. Finally, Northern blot analysis detects an 
mRNA transcript, which hybridizes with the ALP 
oligonucleotide and is identical in length to ALP 
mRNA from cervix uterus. Further purification 
and sequence analysis of tumor-derived ALP will 
confirm whether the tumor-derived protein is iden- 
tical to normal ALP. 
Cytoplasmatic proteins of HS-24 lysed cells 
cross-reacted with antibodies against ALP and one 
protein comigrated with the native ALP form: 
however, three other species had different 
molecular masses. It is possible that the higher 
molecular mass forms are ALP precursors which 
are located inside the cell and are processed during 
secretion. It might also be possible, that the im- 
munoreactive proteins from the cell lysate, those 
not comigrating with the ALP forms, are, in fact, 
different proteins that share only structural 
similarities to ALP. 
Whether the presence of ALP reflects lung cell 
character or tumor cell character or both is not 
clear. However, the fact that (i) ALP is a normally 
occurring protein in lung tissue; (ii) the HS-24 
tumor cell line originating from lung produces 
ALP and (iii) tumor metastasis cell line (SB-3) not 
originating from lung produces no ALP, might im- 
ply that ALP secretion is a character inherent to 
lung cells. 
With the enzyme inhibition assay inhibitory ac- 
tivities against chymotrypsin and trypsin could be 
identified in the supernatants of HS-24 and SB-3 
cell lines. These results together with the blot 
analysis suggest, that SB-3 TCM also contains a 
serine protease inhibitor differing, however, from 
ALP. Further studies will concentrate on the iden- 
tification of the SB-3 cell line specific inhibitor. 
Although it is not yet known whether these tumors 
in vivo exhibit the same high production of in- 
hibitors, a detailed characterization of serine pro- 
tease inhibitors from human lung tumor cell lines 
might be important in understanding the control of 
tumor cell proliferation. 
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